期刊
JOURNAL OF CLINICAL INVESTIGATION
卷 130, 期 12, 页码 6639-6655出版社
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI140046
关键词
-
资金
- Japan Society of the Promotion of Science, Japan [18H02864, 17K09840]
- Diabetes UK
- Wellcome Trust
- Swedish Research council
- Honjo International Scholarship Foundation, Japan
- Novo Nordisk, Denmark
- Research Fellowship of Japan Society for the Promotion of Science Young Scientist DC1
- MSD K.K.
- Kowa Co. Ltd.
- Taisho Pharmaceutical Holdings Co. Ltd.
- Novo Nordisk Pharma Ltd., Japan
- Grants-in-Aid for Scientific Research [18H02864, 17K09840] Funding Source: KAKEN
- MRC [MR/T002107/1] Funding Source: UKRI
By restoring glucose-regulated insulin secretion, glucagon-like peptide-1-based (GLP-1-based) therapies are becoming increasingly important in diabetes care. Normally, the incretins GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) jointly maintain normal blood glucose levels by stimulation of insulin secretion in pancreatic beta cells. However, the reason why only GLP-1-based drugs are effective in improving insulin secretion after presentation of diabetes has not been resolved. ATP-sensitive K+ (K-ATP) channels play a crucial role in coupling the systemic metabolic status to beta cell electrical activity for insulin secretion. Here, we have shown that persistent membrane depolarization of beta cells due to genetic cell-specific Kcnj11(-/-)mice) or pharmacological (long-term exposure to sulfonylureas) inhibition of the K-ATP channel led to a switch from Gs to Gq in a major amplifying pathway of insulin secretion. The switch determined the relative insulinotropic effectiveness of GLP-1 and GIP, as GLP-1 can activate both Gq and Gs, while GIP only activates Gs. The findings were corroborated in other models of persistent depolarization: a spontaneous diabetic KK-Ay mouse and nondiabetic human and mouse beta cells of pancreatic islets chronically treated with high glucose. Thus, a Gs/Gq signaling switch in beta cells exposed to chronic hyperglycemia underlies the differential insulinotropic potential of incretins in diabetes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据